bioAffinity Technologies, Inc. (BIAF)

$2.8725

-0.19 (-6.13%)
Rating:
Recommendation:
-
Symbol BIAF
Price $2.8725
Beta 0.000
Volume Avg. 1.33M
Market Cap 24.042M
Shares () -
52 Week Range 1.31-15.55
1y Target Est -
DCF Unlevered BIAF DCF ->
DCF Levered BIAF LDCF ->
ROE 95.62% Strong Buy
ROA -35.55% Strong Sell
Operating Margin -
Debt / Equity 11.62% Neutral
P/E -
P/B 0.62 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest BIAF news


Ms. Maria Zannes J.D.
Healthcare
Diagnostics & Research
NASDAQ Capital Market

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.